Limb sparing surgery has replaced the amputation surgery in the treatm
ent of limb sarcomas. Recurrent or persistent disease constitutes a ma
jor problem. Local symptoms such as agonizing pain, fractures, tumor f
ungation, inability to walk and inability to maintain daily activities
, further impair the patient's quality of life. In this clinical set-u
p palliative amputation should be considered. Eighteen patients with s
oft-tissue or bone sarcomas and 3 patients with metastatic carcinoma u
nderwent palliative major amputation. Hemipelvectomy was performed in
3 patients, hip disarticulation in 10, knee disarticulation or below-k
nee amputation in 3 patients, shoulder disarticulation in one patient
and forequarter amputation in 4 patients. Local control of the disease
and pain and improvement of the performance status were observed in 1
9 evaluable patients. The mobility was restored in 15 patients with lo
wer limb surgery. The median survival following the procedure was 9 mo
nths. There was only one case of immediate post-operative death. Sever
e phantom pain was not reported by any of the patients. Quality of lif
e was reported to be improved by two-thirds of the patients. To conclu
de, we have found palliative major amputation surgery worth performing
in low-performance status cancer patients with locally advanced disea
se.